CASI Pharma (China-U.S.) in their acquisition of 29 Generic Drug Candidates from Sandoz
Sentynl Therapeutics (U.S.) in their divestiture to Zydus Cadilla (India)
Kinex Pharmaceuticals (U.S.) in the licensing of KX02 (Oncology) to Xiangxue Pharmaceuticals (China)
Medicamenta (Czech Republic) in their divestiture to Glenmark Pharmaceuticals (India)
Morphosys in the Identification and Acquisition of Lanthio Pharma
Sanofi-Aventis Mexico in the Acquisition of Kendrick Farmaceutica (Mexico)
to conduct a Commercial Evaluation as part of its Due Diligence associated with its Agreement with Cell Therapeutics
3M securing Global Licensing Rights for the ClozeX Skin Closure Device
Galen in their Acquisition of Estrostep and Loestrin from Pfizer
Merck Serono in the Identification, Negotiation and Closing of the Licensing Agreement with Intrexon
Morphosys in the Identification and Acquisition of Lanthio Pharma
Kendle in its Acquisition of Mexican CRO Estadisticos y Clinicos Asociados, S.A.
Refer yourself here or call us on 704 906 3402
